Artelo Biosciences, Inc. (ARTL): Operating Cash Flow
-$8.52M
Year ended 2025-12-31
-$12.63M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$8.52M | n/m | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | -$8.35M | n/m | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | -$8.21M | n/m | 2025-03-03, From 2023-01-01 |
| 2022-12-31 | -$8.01M | n/a | 2024-03-25, From 2022-01-01 |
| No annual figure between 2021-08-31 and 2022-12-31. | |||
| 2021-08-31 | -$6.14M | n/m | 2023-03-31, From 2020-09-01 |
| 2020-08-31 | -$4.35M | n/m | 2021-11-29, From 2019-09-01 |
| 2019-08-31 | -$2.79M | n/m | 2020-11-04, From 2018-09-01 |
| 2018-08-31 | -$1.61M | n/m | 2019-12-18, From 2017-09-01 |
| 2017-08-31 | -$216.8K | n/m | 2018-11-29, From 2016-09-01 |
| 2016-08-31 | -$18.5K | n/m | 2017-11-29, From 2015-09-01 |
| 2015-08-31 | -$13.5K | n/m | 2016-11-29, From 2014-09-01 |
| 2014-08-31 | -$15.3K | n/a | 2015-12-11, From 2013-09-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | -$8.52M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$5.52M | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$20.36M | n/m |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | -$1.83M | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | -$3.95M | n/m |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | -$2.87M | n/m |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$16.19M | n/m |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | -$8.64M | n/m |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | -$3.27M | n/m |
Compare ARTL, BFRG, NTHI, ATXI side by side · Screen every company in Pharmaceutical Preparations ↗